Design, synthesis and biological evaluation of 6-(nitroimidazole-1H-alkyloxyl)-4-anilinoquinazolines as efficient EGFR inhibitors exerting cytotoxic effects both under normoxia and hypoxia-Reference-Cited by-同舟云学术

Design, synthesis and biological evaluation of 6-(nitroimidazole-1H-alkyloxyl)-4-anilinoquinazolines as efficient EGFR inhibitors exerting cytotoxic effects both under normoxia and hypoxia

Published:2015-01 Issue: Volume:89 Page:826-834
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Cheng Weiyan,Zhu Shijun,Ma Xiaodong,Qiu Ni,Peng Peng,Sheng Rong,Hu Yongzhou

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference32 articles.

1. ERBB receptors and cancer: the complexity of targeted inhibitors;Hynes;Nat. Rev. Cancer,2005

2. Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status;Rego;Br. J. Cancer,2010

3. Priming with EGFR tyrosine kinase inhibitor and EGF sensitizes ovarian cancer cells to respond to chemotherapeutical drugs;Cao;Cancer Lett.,2008

4. Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer;Mitsudomi;Febs J.,2010

5. Targeting the EGFR-family for therapy: biological challenges and clinical perspective;Patel;Curr. Pharm. Des.,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the future: Innovative design strategies and emerging challenges in HER2-targeted tyrosine kinase inhibitors for cancer therapy;European Journal of Medicinal Chemistry;2024-10

2. Development of new TAK-285 derivatives as potent EGFR/HER2 inhibitors possessing antiproliferative effects against 22RV1 and PC3 prostate carcinoma cell lines;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-04-25

3. Design, Synthesis, Biological Evaluation, and Molecular Dynamics Studies of Novel Lapatinib Derivatives;Pharmaceuticals;2022-12-28

4. Design, synthesis and biological evaluation of novel tumor hypoxia-activated EGFR tyrosine kinase inhibitors;Bioorganic Chemistry;2022-12

5. Nitroimidazole-sulfonamides as carbonic anhydrase IX and XII inhibitors targeting tumor hypoxia: Design, synthesis, molecular docking and molecular dynamics simulation;Journal of Molecular Structure;2022-09